Clinical Trial COGAAML08B1
Title
AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Principal Investigator(s)
Details
- Protocol No. COGAAML08B1
- Open Date: 10/26/2011
- Staging: NA
- Age Group: Children
- Scope: National
- Objective: Molecular features of TMD may influence outcome in Down syndrome patients and predict their risk of developing subsequent leukemia.
- Disease Sites: Pediatrics; Pediatric Leukemia
- Therapies: None Specified
- Drugs: None Specified
- Participating Institutions: Vanderbilt University
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
